The Physiological and Performance Effects of Actovegin during Maximal Cardiopulmonary Exercise Testing: A Randomized, Double-Blind, Placebo-Controlled Trial
Nutrients · 2024
DOI: 10.3390/nu16193332 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Dragana Milovanović und 8 weiteren Autor:innen. Beteiligte Einrichtung: Military Medical Academy, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Exercise Test, Oxygen Consumption, Athletes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medical Sciences, Ministry of Science, Technological Development, and Innovation of the Republic of Serbia, L’Oréal-UNESCO “For Women in Science” Serbian national programme and Humboldt Research Fellowship Programme for Experienced Researchers.
Abstract (Originalsprache)
Background
Evidence regarding the performance-related effects of Actovegin is limited, despite legislated restrictions being in place for this supplement within sport settings.
Objectives
Our study examined the effects of Actovegin on physiological responses and performance during maximal cardiopulmonary exercise in collegiate athletes.
Methods
A randomized, double-blind, placebo-controlled experimental design was adopted. Moderately trained collegiate athletes from various sports were randomly allocated to placebo (n = 8) or Actovegin (n = 8) groups. All athletes consumed three capsules across each day for seven days of loading. Athletes underwent two separate cardiopulmonary exercise tests one week apart. Separate 2 × 2 mixed ANOVAs and effect sizes (ηp2) were used to assess for between- and within-group differences.
Results
A significant time * group effect (p = 0.036, ηp2 = 0.278) was observed in systolic blood pressure. Significant main effects were only observed for time in several variables, with increases in peak oxygen uptake (VO2) (p < 0.001, ηp2 = 0.893), peak minute ventilation (p = 0.004, ηp2 = 0.456), ventilatory equivalents for carbon dioxide (p = 0.002, ηp2 = 0.517), oxygen pulse (p = 0.006, ηp2 = 0.434), VO2 at first ventilatory threshold (p = 0.002, ηp2 = 0.520), velocity at second ventilatory threshold (p < 0.001, ηp2 = 0.997), VO2 at second ventilatory threshold (p < 0.001, ηp2 = 0.628), and peak velocity (p = 0.010, ηp2 = 0.386), and a decrease in respiratory exchange ratio (p < 0.001, ηp2 = 0.695).
Conclusions
Our findings suggest that although physiological and performance alterations were evident with Actovegin supplementation during cardiopulmonary exercise, no further benefits beyond those obtained with a placebo were attained.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Military Medical Academy, 11000 Belgrade, Serbia.
- Faculty of Sport and Physical Education, University of Niš, 18000 Niš, Serbia.
- Faculty of Medical Sciences, Department of Physiology, University of Kragujevac, 34000 Kragujevac, Serbia.
- Department of Human Pathology, 1st Moscow State Medical University IM Sechenov, 119991 Moscow, Russia.
- School of Health, Medical and Applied Sciences, Central Queensland University, Rockhampton 4701, Australia.
- Faculty of Medicine, Department of Physiology, University of Banja Luka, 78101 Banja Luka, Bosnia and Herzegovina.
ORCID-Profile: Dragana Milovanović, Dragan Radovanović, Ivan Srejović, Vladimir Jakovljević, Aaron Scanlan, Emilija Stojanović
Förderung
- Faculty of Medical Sciences
- Ministry of Science, Technological Development, and Innovation of the Republic of Serbia
- L’Oréal-UNESCO “For Women in Science” Serbian national programme and Humboldt Research Fellowship Programme for Experienced Researchers
Zitieren
APA
Milovanović, D., Radovanović, D., Živković, V., Srejović, I., Glišić, M., Jakovljević, V., Scanlan, A., Ponorac, N., & Stojanović, E. (2024). The Physiological and Performance Effects of Actovegin during Maximal Cardiopulmonary Exercise Testing: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu16193332
Vancouver
Milovanović D, Radovanović D, Živković V, Srejović I, Glišić M, Jakovljević V, et al. The Physiological and Performance Effects of Actovegin during Maximal Cardiopulmonary Exercise Testing: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2024. doi:10.3390/nu16193332
BibTeX
@article{Milovanovi2024,
author = {Milovanović, Dragana and Radovanović, Dragan and Živković, Vladimir and Srejović, Ivan and Glišić, Miloš and Jakovljević, Vladimir and Scanlan, Aaron and Ponorac, Nenad and Stojanović, Emilija},
title = {The Physiological and Performance Effects of Actovegin during Maximal Cardiopulmonary Exercise Testing: A Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16193332}
}
EUVIMED